№ lp_1_24115
File format: docx
Character count: 18681
File size: 75 KB
This document provides training material for overdose recognition and naloxone administration aimed at community health workers, students, and leaders, detailing objectives, terminology, and instructional guidelines for effective opioid overdose response.
Note:
Year
Theme:
Overdose Recognition, Naloxone, Opioid Epidemic
Document Type:
Training Material
Target Audience:
Community Health Workers/Representatives, CHW/R Managers, College/University Students, Community Leaders
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2021
Region / City:
Richmond, VA
Topic:
Opioid overdose, Naloxone
Document Type:
Instructional Guide
Organization:
Virginia Department of Behavioral Health and Developmental Services
Author:
N/A
Target Audience:
General public, individuals attending REVIVE! training
Effective Date:
N/A
Date of Last Revision:
September 2021
Year:
2023
Region / City:
California
Theme:
Naloxone Distribution, Overdose Prevention
Document Type:
Application Instructions
Organization / Institution:
California Department of Health Care Services (DHCS)
Author:
N/A
Target Audience:
Healthcare professionals, hospital administrators
Effective Period:
N/A
Approval Date:
N/A
Revision Date:
N/A
Year:
2023
Region / City:
Saskatchewan
Topic:
Opioid overdose prevention, Naloxone administration
Document type:
Guide
Organization / Institution:
Saskatchewan First Nations
Author:
First Nations and Inuit Health Branch (FNIHB)
Target audience:
First Nation organizations, employers, healthcare providers
Effective period:
Ongoing
Approval date:
Not specified
Amendment date:
Not specified
Contextual description:
Guide for First Nations organizations on implementing Take Home Naloxone programs to prevent opioid overdose deaths.
Year:
2015
Region / City:
Massachusetts, US
Topic:
Public health / Medication distribution
Document Type:
Guidance / Instruction
Agency:
Operational Services Division (OSD)
Consulting Agencies:
Department of Public Health (DPH), Drug Control Program (DCP), State Office of Pharmacy Services (SOPS)
Target Audience:
Local government purchasers and public employees
Regulations Referenced:
105 CMR 700.000
Contract:
Statewide Contract MED38
Vendors:
Cardinal Health
Contact Persons:
Edward Cavallari, Elizabeth Landers, Alki Nacopoulos, Donald Rogers
COMMBUYS Requirement:
Executive Branch agencies
Note:
Year
Topic:
Opioid toxicity, Cardiac arrest, Naloxone
Document Type:
Research Article
Target Audience:
Healthcare professionals, Medical researchers
Year:
2021
Region / City:
Richmond, VA
Topic:
Opioid overdose, Naloxone
Document Type:
Instructional Guide
Organization:
Virginia Department of Behavioral Health and Developmental Services
Author:
N/A
Target Audience:
General public, individuals attending REVIVE! training
Effective Date:
N/A
Date of Last Revision:
September 2021
Year:
2025
Note:
Region / City
Topic:
Overdose Case Definitions
Document Type:
Guideline
Organization:
NEMSIS
Target Audience:
EMS Providers, Medical Personnel
Version:
April 24, 2024
Year:
2024
Region / City:
Ohio
Theme:
Emergency Department Overdose Reporting
Document Type:
Compliance Effort
Organization / Institution:
CliniSync, Ohio Department of Health
Author:
Phil Ennen
Target Audience:
Health Systems, Hospitals, Stakeholders in Ohio
Effective Date:
April 8, 2024
Date of Approval:
March 25, 2024
Date of Last Change:
February 2024
Year:
2022
Region / City:
United States
Topic:
Opioid overdose prevention, data collection, and evaluation
Document type:
Evaluation plan
Agency / Institution:
Centers for Disease Control and Prevention (CDC)
Author:
Centers for Disease Control and Prevention (CDC)
Target Audience:
State and local health departments, program implementers, stakeholders in overdose prevention
Period of validity:
2022–2026
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
Not specified
Region / City:
Not specified
Document Type:
Research Table
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Healthcare professionals, researchers
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2021
Region / City:
New Jersey
Subject:
Substance Use Disorders, Law Enforcement, Recovery Support
Document Type:
Public Notice
Institution:
Department of Law and Public Safety
Author:
Office of the Attorney General
Target Audience:
County Prosecutors, Law Enforcement, Recovery Specialists, Healthcare Partners
Period of Effectiveness:
September 1, 2021 - August 31, 2022
Approval Date:
N/A
Amendment Date:
N/A
Year:
2021
Region / City:
Kansas
Topic:
Overdose Fatality Review, Substance Use, Public Health
Document Type:
Meeting Minutes
Organization / Institution:
Kansas Department of Health and Environment (KDHE)
Author:
Ryan Lester, Adrienne Hearrell, Jennifer Donnelly, Julia Baughman, Krista Machado
Target Audience:
Public health professionals, healthcare providers, policy makers
Validity Period:
2021
Approval Date:
July 6, 2021
Modification Date:
Not mentioned
Year:
2020
Region / City:
United States
Topic:
Overdose Surveillance
Document Type:
Plan
Organization / Institution:
CDC
Author:
Centers for Disease Control and Prevention
Target Audience:
State and local governments, non-governmental organizations, healthcare providers, community-based organizations
Period of Validity:
Until completion of dissemination activities
Approval Date:
August 31, 2020
Revision Date:
None
Organization:
Centers for Disease Control and Prevention
Program:
Enhanced State Opioid Overdose Surveillance (ESOOS)
Version:
v1
Subject:
Opioid overdose syndrome definition
Document type:
Public health surveillance guidance
Scope:
Emergency department visit monitoring
Data sources:
ICD-9-CM, ICD-10-CM, SNOMED, chief complaint free text
Related organizations:
National Center for Health Statistics; Council of State and Territorial Epidemiologists; Substance Abuse and Mental Health Services Administration
Intended users:
ESOOS-funded state health departments
Geographic coverage:
United States
Limitations:
Cannot differentiate prescription from illicit opioid overdose; cannot distinguish fentanyl from fentanyl analogs
Organization:
Michigan Public Health Institute
Division:
MDHHS Division of Chronic Disease and Injury Control
Program:
MDHHS Prescription Drug Overdose: Data-Driven Prevention Initiative (PDO: DDPI)
Supervisor:
Jennifer DeLaCruz
Location:
Lansing area, Michigan
Funding Source:
Centers for Disease Control and Prevention grant
Position Type:
Exempt under the Fair Labor Standards Act
Primary Focus:
Prescription opioid and heroin overdose primary prevention
Key Responsibilities:
Program development, contract monitoring, grant reporting, budget oversight, stakeholder coordination, technical assistance
Education Requirement:
Master’s degree in public health, social work, or closely related health field
Experience Requirement:
Minimum one year experience in substance use disorder, health education, outreach, or project management
Collaborating Agencies:
Michigan Department of Health and Human Services; Department of Licensing and Regulatory Affairs
Work Requirements:
Significant travel; valid driver’s license; extensive computer use
Reporting Obligations:
Federal performance and financial reporting
Year:
2024
Region / City:
Massachusetts
Topic:
Opioid Overdose Rescue and Prevention
Document Type:
Training Guide
Organization / Institution:
Health Resources in Action (HRiA), Massachusetts Department of Public Health
Author:
BeHERE Initiative
Target Audience:
Trainers and participants in overdose prevention training
Duration:
120 minutes
Approval Date:
April 2024
Date of Last Update:
April 2024
Year:
2027
Region / Jurisdiction:
Maryland
Document Type:
Grant Program Application Form
Program:
Competitive Grant Program
Issuing Office:
Maryland’s Office of Overdose Response (MOOR)
Subject Area:
Overdose prevention, substance use disorder services, and public health initiatives
Strategic Priorities:
Prevention; Drug User Health; Treatment; Recovery; Public Safety
Eligible Project Areas:
Social determinants of health; adverse childhood experiences and trauma; evidence-based prevention; low-threshold services; risk reduction tools; overdose education and naloxone distribution; medications for opioid use disorder; barrier reduction in care; holistic care for people who use drugs; employment and recovery supports; community-based recovery; criminal justice health impact reduction; reentry service connections
Application Components:
Project Summary; Problem Statement; Program Measurement and Performance Indicators; Timeline; Budget Detail and Narrative; Program Sustainability Plan
Applicant Information Required:
Organization name, FEIN, point of contact, position, phone, email
Certification Requirement:
Applicant signature and confirmation of accuracy of submitted information
Administering Authority:
Maryland’s Office of Overdose Response
Year:
2026
Region / City:
Global
Subject:
Emergency treatment of opioid overdose
Document Type:
Pharmaceutical product monograph
Organization / Institution:
OPVEE™ Pharmaceuticals
Author:
OPVEE™ Research and Development Team
Target Audience:
Healthcare professionals and emergency responders
Dosage Form:
Nasal spray
Active Ingredient:
Nalmefene hydrochloride
Indications:
Treatment of known or suspected opioid overdose in patients 12 years and older
Pharmacokinetics:
Nasal administration, onset 2.5–5 minutes, duration ~6 hours above EC50
Safety Considerations:
Pregnancy, lactation, pediatric and geriatric usage, renal and hepatic impairment
Contraindications:
Hypersensitivity to nalmefene or other components
Adverse Effects:
Possible acute withdrawal in opioid-dependent patients, recurrence of respiratory depression
Year:
2026
Region / City:
Global
Topic:
Transboundary river research, Natural Language Processing, Named Entity Recognition, Python
Document type:
Research methodology
Organization / Institution:
None mentioned
Author:
Sahana et al.
Target audience:
Researchers in the field of natural language processing and transboundary river studies
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2023
Region / City:
Long Branch, New Jersey
Topic:
Sustainability, Green Business Recognition
Document Type:
Application Form
Organization / Institution:
City of Long Branch
Author:
Long Branch Green Team
Target Audience:
Local businesses and non-profits
Period of Validity:
Two years from approval date
Approval Date:
Not specified
Date of Last Revision:
Not specified